A 52-year-old woman with type 2 diabetes mellitus (HbA1c 8.2%) on metformin and glibenclamide presents with a 3-day history of severe vomiting and abdominal pain. On examination, she is dehydrated, respiratory rate 28/min, blood pressure 100/65 mmHg. Arterial blood gas shows pH 7.28, HCO₃⁻ 12 mEq/L, PaCO₂ 28 mmHg. Capillary blood glucose is 380 mg/dL. Serum osmolality is 310 mOsm/kg. Serum ketones are negative. Which of the following best explains why this patient is NOT in diabetic ketoacidosis (DKA) despite severe hyperglycemia and metabolic acidosis?

Explanation

## Differential Diagnosis: HHS vs. DKA This patient has **Hyperglycemic Hyperosmolar State (HHS)**, not diabetic ketoacidosis, despite severe hyperglycemia, dehydration, and metabolic acidosis. ## Key Distinction: Why No Ketosis? **High-Yield:** The critical difference between type 1 DKA and type 2 HHS is the **presence of residual insulin secretion** in type 2 diabetes. ### Insulin's Anti-Lipolytic Effect | Mechanism | DKA (Type 1) | HHS (Type 2) | |-----------|-------------|-------------| | **Insulin level** | <2 mIU/L (absent) | 5–15 mIU/L (low but present) | | **Lipolysis** | Unopposed; FFA ↑↑↑ | Partially suppressed by residual insulin | | **Ketogenesis** | Massive (β-hydroxybutyrate >> acetoacetate) | Minimal to absent | | **Serum ketones** | Positive (>3 mmol/L) | Negative or trace | | **Anion gap acidosis** | Yes (due to ketones) | Non-anion gap (due to uremia, lactate) | | **Serum osmolality** | 300–310 mOsm/kg | >320 mOsm/kg (often >330) | | **Mortality** | 1–5% | 5–15% | **Key Point:** Even though type 2 patients have **absolute insulin deficiency relative to glucose**, they retain **enough insulin to suppress hormone-sensitive lipase** and prevent uncontrolled lipolysis. This residual insulin (5–15 mIU/L) is insufficient to lower glucose but sufficient to block free fatty acid (FFA) mobilization. ### Pathophysiology of HHS ```mermaid flowchart TD A[Type 2 DM + Stress<br/>Infection, dehydration, etc.]:::outcome --> B[Hyperglycemia<br/>Glucose > 600 mg/dL]:::outcome B --> C{Insulin level?}:::decision C -->|Absent<br/>Type 1 DKA| D[Unopposed lipolysis<br/>FFA ↑↑↑]:::action D --> E[Ketogenesis ↑↑↑<br/>Ketones positive]:::outcome E --> F[Metabolic acidosis<br/>pH < 7.3]:::urgent C -->|Low but present<br/>Type 2 HHS| G[Partial suppression<br/>of lipolysis<br/>FFA mildly ↑]:::action G --> H[Minimal ketogenesis<br/>Ketones negative]:::outcome H --> I[Hyperglycemic<br/>hyperosmolar state<br/>Osmolality > 320]:::outcome B --> J[Osmotic diuresis<br/>Severe dehydration]:::action J --> K[Prerenal azotemia<br/>Non-anion gap acidosis]:::outcome ``` **Clinical Pearl:** This patient's metabolic acidosis (pH 7.28, HCO₃⁻ 12) is **non-anion gap** (due to uremia and lactate from dehydration), not anion-gap acidosis from ketones. Calculate anion gap: Na⁺ - (Cl⁻ + HCO₃⁻). In HHS, AG is typically normal or only mildly elevated. ## Why This Patient Has HHS, Not DKA 1. **Negative serum ketones** — the hallmark of HHS 2. **Type 2 diabetes** — retains some beta cell function 3. **Severe dehydration** (osmolality 310) — osmotic stress dominates 4. **Non-anion gap acidosis** — from uremia, not ketones ## Management Differences | Intervention | DKA | HHS | |--------------|-----|-----| | **IV insulin** | High-dose (0.1 U/kg/hr) | Low-dose (0.05 U/kg/hr) | | **IV fluids** | 1–1.5 L/hr initially | 0.5–1 L/hr (slower, avoid cerebral edema) | | **K⁺ replacement** | Aggressive | Cautious (HHS patients often have higher K⁺) | | **Bicarbonate** | If pH <6.9 | Rarely needed | **Mnemonic:** **HISS** = **H**yperglycemia, **I**nsulin present (low), **S**evere dehydration, **S**evere hyperglycemia (>600 mg/dL). [cite:Harrison 21e Ch 417; Guyton & Hall Physiology 14e Ch 78]